[go: up one dir, main page]

HUP0300875A3 - Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine - Google Patents

Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine

Info

Publication number
HUP0300875A3
HUP0300875A3 HU0300875A HUP0300875A HUP0300875A3 HU P0300875 A3 HUP0300875 A3 HU P0300875A3 HU 0300875 A HU0300875 A HU 0300875A HU P0300875 A HUP0300875 A HU P0300875A HU P0300875 A3 HUP0300875 A3 HU P0300875A3
Authority
HU
Hungary
Prior art keywords
olanzapine
hydrates
conversion
preparation
crystalline forms
Prior art date
Application number
HU0300875A
Other languages
Hungarian (hu)
Original Assignee
Reddy S Lab Ltd Hyderabad Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy S Lab Ltd Hyderabad Dr filed Critical Reddy S Lab Ltd Hyderabad Dr
Publication of HUP0300875A2 publication Critical patent/HUP0300875A2/en
Publication of HUP0300875A3 publication Critical patent/HUP0300875A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0300875A 2000-08-31 2001-03-07 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine HUP0300875A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN709CH2000 2000-08-31
IN711CH2000 2000-08-31
PCT/US2001/007258 WO2002018390A1 (en) 2000-08-31 2001-03-07 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine

Publications (2)

Publication Number Publication Date
HUP0300875A2 HUP0300875A2 (en) 2003-12-29
HUP0300875A3 true HUP0300875A3 (en) 2005-09-28

Family

ID=26324874

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300875A HUP0300875A3 (en) 2000-08-31 2001-03-07 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine

Country Status (12)

Country Link
EP (1) EP1313742A1 (en)
JP (1) JP2004507548A (en)
AU (1) AU2001243475A1 (en)
BR (1) BR0114031A (en)
CA (1) CA2420987A1 (en)
CZ (1) CZ2003566A3 (en)
HU (1) HUP0300875A3 (en)
IL (1) IL154688A0 (en)
NO (1) NO20030926L (en)
RU (1) RU2003108745A (en)
SK (1) SK2502003A3 (en)
WO (1) WO2002018390A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2464306A1 (en) * 2001-10-29 2003-05-08 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
WO2003091260A1 (en) * 2002-04-23 2003-11-06 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
AU2002251329A1 (en) * 2002-04-25 2003-11-10 Generics (Uk) Limited Novel crystalline forms of celecoxib and other compounds
PL196814B1 (en) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Method of obtaining polymorphous form of i olansapine
ATE500258T1 (en) 2002-05-31 2011-03-15 Sandoz Ag METHOD FOR PRODUCING OLNZAPINE FORM I
SI21270A (en) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Crystal forms of olanzapine and procedures for their preparation
PL202856B1 (en) * 2002-12-20 2009-07-31 Adamed Spo & Lstrok Ka Z Ogran Method of obtaining pharmaceutically pure polymorphic form of I olanzapine
WO2004058773A1 (en) * 2002-12-24 2004-07-15 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
CN1906201A (en) 2003-12-22 2007-01-31 特瓦制药工业有限公司 Methods of preparing olanzapine
WO2005070938A1 (en) 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
AR047460A1 (en) * 2004-01-27 2006-01-18 Synthon Bv PROCESS FOR THE MANUFACTURE OF 2-METHYL-4- (4-METHYL-1-PIPERAZINYL) ACETATE -10H-TIENO [2,3-B] [1,5] BENZODIAZEPIN (OLANZAPINE ACETATE)
WO2005080401A1 (en) * 2004-02-19 2005-09-01 Neuland Laboratories Limited Process for the preparation of olanzapine form 1 useful as antipsychotic drug
WO2005107375A2 (en) * 2004-05-06 2005-11-17 Matrix Laboratories Ltd Process for the preparation of olanzapine form-i
ES2427048T3 (en) 2004-07-14 2013-10-28 Jubilant Life Sciences Limited A process for producing a pure form of 2-methyl-4- (4-methyl-1-piperazinyl) -10H-thieno [2,3-B] [1,5] benzodiazepine
EP1781666A1 (en) * 2004-07-14 2007-05-09 Shasun Chemicals and Drugs Limited Improved process for making form i of olanzapine.
ES2253091B1 (en) 2004-07-27 2007-02-01 Inke, S.A. MIXED SOLVATO OF OLANZAPINE, PROCEDURE FOR OBTAINING AND PROCEDURE OF OBTAINING THE FORM I OF OLANZAPINE FROM THE SAME.
WO2006025065A1 (en) * 2004-08-31 2006-03-09 Lee Pharma Private Limited A process for the preparation of anhydrous olanzopine hydrochloride of form-1
ES2303462B1 (en) * 2004-09-06 2009-06-05 Shasun Chemicals And Drugs Limited NEW PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICALLY PURE OLANZAPINE POLYMORPHIC FORM I.
WO2006073886A1 (en) * 2005-01-05 2006-07-13 Eli Lilly And Company Olanzapine pamoate dihydrate
US20100174066A1 (en) * 2005-03-21 2010-07-08 Venkataraman Sundaram Process for preparing crystalline form i of olanzapine
HUP0501046A2 (en) * 2005-11-11 2007-08-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of olanzapine
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
PL381564A1 (en) 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent The manner of production of basically clean variety of polymorphic olanzapine
WO2008139228A2 (en) * 2007-05-15 2008-11-20 Generics [Uk] Limited Process for the purification of olanzapine
EP2292624A1 (en) 2009-07-20 2011-03-09 LEK Pharmaceuticals d.d. Process for the purification of olanzapine
CN102093386B (en) * 2011-01-05 2016-06-01 浙江华海药业股份有限公司 A kind of method preparing Zyprexa crystal form II
JP6008734B2 (en) * 2012-12-20 2016-10-19 株式会社トクヤマ Olanzapine type II crystal production method
KR102543559B1 (en) 2016-05-31 2023-06-13 다이호야쿠힌고교 가부시키가이샤 Sulfonamide compound or salt thereof
ES2969901T3 (en) 2017-11-29 2024-05-23 Taiho Pharmaceutical Co Ltd Benzoic Acid Cocrystal and Sulfonamide Compound for Tumor Treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
CN1146567C (en) * 1996-09-23 2004-04-21 伊莱利利公司 Olanzapine dihydrate D

Also Published As

Publication number Publication date
IL154688A0 (en) 2003-09-17
SK2502003A3 (en) 2004-03-02
BR0114031A (en) 2003-09-09
NO20030926D0 (en) 2003-02-27
JP2004507548A (en) 2004-03-11
CZ2003566A3 (en) 2004-01-14
WO2002018390A1 (en) 2002-03-07
EP1313742A1 (en) 2003-05-28
NO20030926L (en) 2003-04-24
CA2420987A1 (en) 2002-03-07
RU2003108745A (en) 2005-01-10
HUP0300875A2 (en) 2003-12-29
AU2001243475A1 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
HUP0300875A3 (en) Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
HU0100033D0 (en) Stuffed foodproduct and process for its production and equipment for realization of process
SG92703A1 (en) Method of producing profiled sheets as prosthesis
HUP0300592A3 (en) Process for the preparation of 2-halobenzoic acid derivatives
PL361277A1 (en) Use of thienopyrimidines
AU2001290311A1 (en) Thienopyrimidine compounds and their salts and process for preparation of both
IL150985A0 (en) Process for preparing crystalline form i of cabergoline
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
GB0007307D0 (en) Crystalline form || of cabergoline
PL340132A1 (en) Method of obtaining modified microcrystalline chitosamine
GB0007309D0 (en) Crystalline form V|| of cabergoline
GB0000512D0 (en) Method of and line for breadcrumb production
AU1396502A (en) Amorphous form of cell cycle inhibitor
AU8824201A (en) Process for the preparation of dinapsoline
HUP0303907A3 (en) Improved process for preparation of steroids
GB0104265D0 (en) Method of forming coatings
PL345527A1 (en) Method of makinbg glassware
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
PL361052A1 (en) Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
HU0103554D0 (en) Method for production of methylene-karbamide polimers
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
HU0104563D0 (en) Process for producing of food-enzymes
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
AU2003243153A8 (en) Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
AU8626801A (en) Method of forming complex